Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Rheumatology
SLE
Questions discussed in this category
Is there a preferred JAK inhibitor for the treatment of alopecia associated with childhood-onset systemic lupus erythematosus?
1 Answer available
In patients with SLE and coexisting knee osteoarthritis, how useful is musculoskeletal ultrasound particularly power Doppler in distinguishing an SLE inflammatory arthritis flare from an OA flare when serologies and inflammatory markers may not be helpful?
Given that OA can also demonstrate Doppler activity - are there ultrasound features that favor SLE over OA, or is the overlap too great for this to be...
1 Answer available
What is your approach to management of recurrent Kikuchi-Fujimoto Disease?
1 Answer available
Which serologic tests are most helpful when evaluating for suspected drug-induced lupus?
2 Answers available
Does treatment with hydroxychloroquine increase the risk of hypertension or exacerbate pre-existing hypertension?
2 Answers available
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
2 Answers available
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
1 Answer available
27448
27537
26210
27242
27140
25695
25636
Papers discussed in this category
JAMA Dermatol,
Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Current opinion in rheumatology, 2014 Jan
Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.
Related Topics in Rheumatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers